Qijian mixture, a new traditional Chinese medicine (TCM) formula comprising of Astragalus membranaceus, Ramulus euonymi, Coptis chinensis and Pueraria lobata, was designed to ameliorate the type 2 diabetes (T2D), and its safety and efficacy were evaluated in the research by metabonomics, gut microbiota and system pharmacology. To study the hypoglycemic effect of Qijian mixture, male KKay mice (28-30 g, 8-9 week) and C57/BL6 mice (18-19 g, 8-9 week) were used. Thirty KKay diabetic mice were randomly distributed into 5 groups, abbreviated as Model group (Model), Low Qijian Mixture group (QJM(L)), High Qijian Mixture group (QJM(H)), Chinese Medicine (Gegen Qinlian Decoction) Positive group (GGQL), and Western Medicine (Metformin hydrochloride) Positive group (Metformin). C57/BL6 was considered as the healthy control group (Control). Moreover, a system pharmacology approach was utilized to assess the physiological targets involved in the action of Qijian mixture. There was no adverse drug reaction of Qijian mixture in the acute toxicity study and HE result, and, compared with Model group, Qijian mixture could modulate blood glycemic level safely and effectively. Qijian Mixture was lesser effective than metformin hydrochloride; however, both showed similar hypoglycemic trend. Based on 1 H NMR based metabonomics study, the profoundly altered metabolites in Qijian mixture treatment group were identified. Qijian mixture-related 55 proteins and 4 signaling pathways, including galactose metabolism, valine, leucine and isoleucine degradation metabolism, aminoacyl-tRNA biosynthesis metabolism and alanine, aspartate and glutamate metabolism pathways, were explored. The PCoA analysis of gut microbiota revealed that Qijian mixture treatment profoundly enriched bacteroidetes. In addition, the system pharmacology paradigm revealed that Qijian mixture acted through TP53, AKT1 and PPARA proteins. It was concluded that Qijian mixture effectively alleviated T2D, and this effect was linked with the altered features of the metabolite profiles and the gut microbiota.
Introduction
One of the most prevalent disorders in the world is type 2 diabetes (T2D) [1] , which is attributed to low-intensity inflammation, insulin resistance and ␤-cell dysfunction [2] . In 2010, 8.3% of the adults were suffering from diabetes, while approximately 90% of them were having T2D [3] . By 2030, the projected proportion of adults having T2D will be 9.9% [3] . One of the crucial risk factors of T2D is obesity that is accompanied with low-intensity inflammation and insulin resistance [4] .
The development of obesity depends on the properties of gut microbiota [5] . For instance, the subcutaneous infusion of Escherichia coli endotoxin triggers insulin resistance and obesity [6] . Diabetic patient's gut contents have higher proportion of Betaproteobacteria than that of healthy individuals [7] . Faecalibacterium prausnitzii are in lesser, while Clostridium bolteae exists in higher proportion in diabetic patient's faeces than that of healthy control [8] . The invasion of intestinal bacteria into the neighboring tissues is also increased in diabetic mice [9] . The administration of Enterobacter cloacae B29, isolated from diabetic individual's gut, to mice results in the development of obesity and insulin resistance [10] . In summary, obesity and diabetes are partly induced by an impaired gut microbiota, which could be targeted to manage T2D.
Many studies have been conducted to target gut microbiota for the treatment of obesity [11, 12] . The clinical use of berberine, an active ingredient of Coptis chinensis and formerly utilized for treating bacterial diarrhea [13] [14] [15] , has proved its efficacy against diabetes [16] . In traditional Chinese medicines (TCM), Coptis chinensis has been utilized to treat diarrhea for several centuries. A previous study has documented the induction of obesity and insulin resistance in control Wistar rats using high fat-diet. However, in test group rats, berberine supplementation exerted a preventive effect on the obesity and insulin resistance and ameliorated the inflammatory condition, through the diminishing impact on opportunistic pathogen count and enriching effect on short-chain fatty acid synthesizing bacteria [17] .
Owing to sharing of impaired gut microbiota between diarrhea and T2D, the antidiarrheal drugs including berberine may effectively treat T2D. Berberine-containing Qijian mixture is a new combined TCM prescription for treating T2D. Qijian mixture contains 4 herbs including Astragalus membranaceus, Ramulus euonymi (Winged Euonymus Twig), Coptis chinensis and Pueraria lobata. These four herbs are on the top of 10 herbs used in TCM for treating diabetes. Based on modern pharmacological research, there are two-way effect of Astragalus membranaceus on the regulation of blood glucose, i.e. it reduces blood glucose as well as improves the pathological lesion of diabetic kidney [18] . Ramulus euonymi is utilized by many TCM clinicians as the main ingredient for treating T2M. Astragalus membranaceus and Ramulus euonymi have already been standardized and used as combined prescription [19] , however these four herbs have never been prescribed together for T2D. Thus, the underlying mechanism of Qijian mixture of glycemic control is also not investigated yet. It is also hypothesized that the gut microbiota could play important role in glycemic effectiveness of Qijian mixture in T2D.
A wide array of in silico studies have reported the significance of network pharmacology in assessing mechanism of action of herbs or botanicals during the process of drug discovery [20] . This modality is valuable in ameliorating drug efficacy through interaction channels of different signaling proteins in the physiological conditions [21] . These signaling proteins create an interaction network that is involved in the biological functions [22] . The biological functions are annotated via gene ontology (GO) enrichment analysis, based on the genome project [23] . The network analysis and GO enrichment analysis altogether are employed to examine the molecular mechanisms of drug activities.
The present study is carried out in rats to assess the therapeutic effectiveness and safety of Qijian mixture in glycemic control. Moreover, the effect of Qijian mixture on gut microbiota features in T2D alleviation process is also studied. In addition, network pharmacology is applied to explore multi-target regulation of sugar level and the underlying mechanisms and signaling pathways of Qijian mixture against T2D.
Materials and methods

Materials
UPLC grade acetonitrile and formic acid were obtained from Fisher Scientific (Fair Lawn, NJ, USA) and Sigma Aldrich (St. Louis, MO, USA), respectively. Ultrapure water was obtained from Watsons Waters (Guangzhou, China). All other chemicals were purchased through market resources and were used as it is.
Animal Care Committee of Beijing University of Chinese Medicine approved this research (Project No. 81102730). The animal experimental procedures were conducted according to the guidelines of China legislations on the ethical use and care of laboratory animals.
Conception of Qijian mixture and dosage levels
The CNKI database (http://www.cnki.net/) was searched to find prescriptions having word "diabetes". Resultantly, a total of 97 prescriptions were acquired [19] . All the information of these 97 prescriptions was typed into the Epidata 3.1 [24] , which could be used to analyze the ingredients relationship of current prescriptions, to build the prescription database for diabetes. Top 10 high-frequency herbs and their relevant DR (degree of relevancy) values are shown in Supplementary Online Table 1 . Finally, a dosage of 1.795 g/kg/d was chosen for Low Qijian Mixture group (QJM(L)), and 5.385 g/kg/d for High Qijian Mixture group (QJM(H)). In addition, a standardized berberine-containing Chinese herbal formula, Gegen Qinlian Decoction (GGQL), has been used in Shang Han Lun since the East Han Dynasty, and according to the modern clinical research, Gegen Qinlian Decoction could improve the T2D, so it was chosen as the Chinese Positive Medicine [25] . The Gegen Qinlian Decoction tablet was offered by Jilin Wanton pharmaceutical group (Meihekou City, Jilin Province, China), and according to the equivalent conversion between animal and people by body surface area, the dosage of 0.942 g/kg/d was chosen in present study for mice per day. Moreover, Metformin hydrochloride (Shiguibao Pharmaceutical Company, Shanghai, China) was administered in a dose of 0.314 g/kg/d as Western Positive Medicine. Additionally, C57/BL6 (Control) and Model group (Model) received physiological saline solution at 10 ml/kg/d. The drugs were administered for a total of 8 weeks.
UPLC chromatographic conditions
For the identification and quantification of Qijian mixture, UPLC chromatographic analysis was conducted. For this test, Qijian mixture (0.1 g) was added to 1.5 ml centrifuge tube containing 1.0 ml water, sonicated for 30 min, and then centrifuged (Eppendorf, Melbourne, Australia) at 14,000 rpm for 10 min. A supernatant (200 l) was transferred to the sample vial. The UPLC analysis was carried out on a Waters UPLC (two LC-20ADXR solvent delivery units, a binary solvent manager, sampler manager, and a SYNAPT G2 Q-TOF detector). The chromatographic separation was performed using ACQUITY UPLC ® BEH C18 column (2.1 mm × 100 mm, 1.7 m) at 40 • C. 0.1% aqueous formic acid (A) and acetonitrile containing 0.1% formic acid (B) were used as the mobile phase for analysis. The flow rate was set at 0.4 ml/min. The elution condition was applied with a gradient program as follows: 5%-20% B for 0-10 min, 20%-25% B for 10-16 min, 25-40% B for 16-20 min, 40%-95% B for 20-20.1 min, 95-95% B for 20.1-22 min, 95%-5% B for 22-22.1 min, 5-5% B for 22.1-30 min 2 l of sample was injected into UPLC system for analysis.
Acute toxicity study
The peak concentration of Qijian Mixture consisted of 15.6 g/10 ml of water. C57/BL6 mice (18-19 g, 8-9 week old) were purchased from HFK Bioscience Company, Beijing (Order ID 11401300029505). During housing, the animals were kept in standard polypropylene cages (one mice/cage) and the room temperature and the humidity were maintained at 12/12-h light-dark cycle. The regular chow comprised of 5% fat, 53% carbohydrate and 23% protein.
After 3 days of adaptive breeding, 40 mice were randomly divided into 4 groups, 10 male mice in Qijian Mixture group (group 1), 10 female mice in Qijian Mixture group (group 2), 10 male mice in control group (group 3), and 10 female mice in control group (group 4). Group 1 and 2 received single dose of Qijian Mixture 62.4 g/Kg of mice weight (0.4 ml/10 g mice weight), while group 3 and 4 received physiological saline solution 0.4 ml/10 g of mice weight through intragastric route. Of these 40 mice, there was no death, so median lethal dose and maximal tolerance dose could not be determined.
Then we conducted the maximum dosage administration test with triplication of the peak concentration in a day. After without food and with water for 12 h, other 40 mice were randomly divided into 4 groups, as above. These 4 groups received Qijian Mixture and physiological saline solution in the same dose as stated above, but for 3 times a day. Their body weight was measured at day 7 and 14. The possible toxic reactions were observed during the subsequent 14 days [18] .
Animals and groups
Male KKay mice (28-30 g, 8-9 week) and C57/BL6 mice (18-19 g, 8-9 week) were purchased from HFK Bioscience Company, Beijing (Order ID 11401300029505). During housing, the animals were kept in standard polypropylene cages (one mice/cage) and the room temperature and the humidity were maintained at 12/12-h lightdark cycle. Regular chow comprising of 5% fat, 53% carbohydrate and 23% protein for C57/BL6, and high-fat diet consisting of 17.9% fat, 48% carbohydrate and 17.5% protein for KKay mice were procured from HFK Bioscience Company, Beijing.
After 3 weeks of adaptive breeding, the weight and fasting blood glucose (FBG) of all mice were measured. KKay mice with the fasting blood glucose ≥ 7.8 mmol/L were considered the diabetic [26] . Thirty diabetic mice were randomly divided into 5 groups, 6 mice/group. The groups were named as Model group (Model), Low Qijian Mixture group (QJM(L)), High Qijian Mixture group (QJM(H)), Chinese Medicine (Gegen Qinlian Decoction) Positive group (GGQL), and Western Medicine (metformin hydrochloride) Positive group (Metformin). C57/BL6 was considered as the healthy control group (Control).
The body weight and FBG were measured every week. Mice were kept fasting for 12 h, their blood was collected from tail vein, and FBG value was measured by glucometer (Johnson Medical Equipment Company, Shanghai, China) in triplicate for each mouse. The gavage dosage for all groups was adjusted according to the latest body weight.
Sample collection and preparation
At the eighth week of adaptive breeding, the oral glucose tolerance test (OGTT) [27] (glucose 2 g/kg) was conducted. Next day, all the rats were anesthetized by 4% chloral hydrate with 0.20 ml/20 g, and then sacrificed for blood, liver and kidney samples.
Whole blood was collected by removing eyeball. The blood was further processed to get serum that was stored at −80 • C for lab tests.
Each liver and kidney tissues was divided into 2 pieces: one was stored in the formalin for histological examination, and other was snap frozen in liquid nitrogen, and stored at −80 • C until NMR metabolomics analysis was conducted.
For NMR analysis, homogenate was prepared [28] by thawing liver and kidney samples (110 mg) at room temperature, followed by addition of 4 ml/g (wet weight) of 100% methanol, and subsequently adding 1.25 ml/g (wet weight) of deionized water. The homogenate was extracted by using 4 ml/g (wet weight) of chloroform and 1.25 ml/g (wet weight) of deionized water, and afterwards incubating at 4 • C for 10 min. After a centrifugation of extract samples at 5000g at 4 • C for 10 min, the supernatant aqueous layer was lyophilized. The extract powder was dissolved in 600 l of phosphate buffer (0.1 M Na 2 HPO 4 /NaH 2 PO 4 , pH = 7.4), subjected to centrifugation at 13,000g at 4 • C for 15 min. The upper solution layer (550 l) was subsequently transferred into a 5 mm NMR tube for NMR analysis.
Faeces of all mice were collected at the eighth week for the gut microbiota analysis. 
Histological study
Hematoxylin-eosin (HE) staining was performed to visualize changes in the liver and kidney tissues. In 4% paraformaldehyde solution, liver and kidney issues from Control, Model, QJM(H), and Metformin groups were fixed for more than 48 h, and then prepared for paraffin sectioning. Serial sections (3 m) were cut, processed for HE staining, and then analyzed under light microscope. An optical microscope, with 400× magnification, was used to visualize the images [29] .
NMR analysis
VARIAN VNMRS 600 MHz NMR spectrometer (VARIAN Inc, Palo Alto, Calif) was used to analyze liver and kidney samples at 298 K [28] . The operating condition was 599.871 MHz utilizing a 5-mm inverse-proton (HX) triple resonance probe with z-axis gradient coil. The functioning procedure involved a standard sequence, i.e. single dimensional spectrum employing the initially augmented NOESY sequence (RD-90 • -t1−90 • -tm−90 • -ACQ) with water inhibition: water inhibition was attained by striking a radiation on water peak during a mixing time (tm) of 100 ms and the relaxation delay (RD) of 2.0 s t1 and 90 • pulse length was adjusted to 4 s and 9.8 s, respectively. Each resulting spectrum had a spectral width of 20 ppm and was characterized with a buildup of 128 transients into 64 K data. Before Fourier transformation, an exponential factor with a 0.5 Hz line-broadening factor was used weighting the free induction decay (FID). The metabolites in the selected extract samples were identified by using standard COSY, TOCSY, HMBC and J-resolved spectra. MestReNova7.1.0 software (Mestrelab Research, Spain) was used for the correction of manually phased 1H NMR spectra. The methyl group of lactate at ı 1.336 was used as reference for all the spectra. Water suppression effects were eliminated by deleting the region of ı 4.7-5.2. The spectral region ı 0.5-4.7 and ı 5.2-9.0 was spontaneously data condensed to 1700 integral fragments of alike length (0.005 ppm). Each fragment region was further used for the calculation of the area under the spectrum, named as an integral value. Total sum of the spectrum was achieved by normalization of the integrated data. Finally, multivariate statistical analysis was applied to give the same integration value for each spectrum.
Gut microbiota analysis
The sequencing of gut microbiota was conducted using five steps, as stated here: (i) Extraction of genome DNA; (ii) Amplicon Generation; (iii) PCR Products quantification and qualification; (iv) PCR Products Mixing and Purification; and (v) Library preparation and sequencing. The detailed method is shown in the Supplementary Material.
Statistical analysis
SIMCA-P (version 14.1, Umetrics AB, Umea, Sweden) was utilized for multivariate statistical analysis of the integral values obtained from NMR findings. While, the mean centered data was used for principle component analysis (PCA) [30] [31] [32] . The modelling of sample classes was carried out using the orthogonal projection to latent structure-discriminant analysis (OPLS-DA) algorithm at a unit variance-scaled modality, to alleviate the separation due to groups and lessen other biological analytical changes. The first and second principal component was used to show the PCA and PLS-DA score plots, while the first principal component and the orthogonal component was used to visualize OPLS-DA. METLAB scripts was downloaded from http:// www.mathworks.com, processed for in-house modification and used to generate the coefficient plots, color-coded with absolute value of coefficients (r) [33] . R2Y (cum) was used to estimate the "goodness of fit" of the model, and Q2 (cum) to estimate the ability of prediction. After the OPLS-DA test, only the integral, with variable importance in the projection (VIP) values >1.0 and p-value < .05, from the Student t-test, was considered the potential differential metabolite. The disturbed metabolites and metabolic pathways were identified by open database sources, including Human Metabolome Database (http://www.hmdb.ca/), KEGG (http://www.genome.jp/kegg/pathway.html), and MetaboAnalyst (http://www.metaboanalyst.ca/faces/home.xhtml).
Heat maps was conducted using Pyplot (Version 2.0.2, http:// matplotlib.org/index.html).
Statistical analyses were performed using SPSS software version 19.0 (IBM Corp., Armonk, New York). Based on the test of normality and homogeneity of variance, one-way ANOVA or rank sum test were adopted for data analysis, and p-value < .05 was considered statistically significant.
Data analysis of gut microbiota was conducted using four steps, as stated here: (i) Paired-end reads assembly and quality control; (ii) OTU cluster and Species annotation; (iii) Alpha Diversity and (iv) Beta Diversity. The detailed data is shown in the Supplementary Material.
Systematic investigation of mechanism of antidiabetic effect
Qijian formula contains four herbs, Astragalus membranaceus, Ramulus euonymi, Coptis chinensis and Pueraria lobata. Firstly, the literature on these herbs was extensively studied utilizing TCMSP (Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform) [34] to retrieve all chemical ingredients and their protein targets in Homo sapiens. Secondly, after ascertaining the molecular targets for their association with diabetes, the identified targets were utilized for further analysis. Thirdly, the identified targets were plotted as interaction network using STITCH 5.0 database (http://stitch.embl.de/, accessed in May 2017) [35] to systematically investigate the mechanism of Qijian mixture. Fourthly, Gene Ontology (GO) enrichment analysis of the potential target genes was conducted using ClueGO plugin of Cytoscape 3.4.0 software, to investigate the biological pathways for assessing the mechanism of Qijian mixture and its pharmacodynamics effect [36] . For ClueGo analysis, the level of significance was set at 0.05, adopting medium network type option and two-sided hypergeometric test with a Bonferroni correction. Finally, organic layout algorithm was opted to visualize the functional network.
Results
Establishment of qijian mixture
According to the searching result of CNKI and Epidata, top 10 high-frequency herbs and their degree of relevancy are shown in Supplementary Online Table 1 . Based on the previous studies on different ratios of Astragalus membranaceus and Ramulus euonymi (3:1, 4: 5, 3:2, 4:3, 5:1, 12:1, 1:3), ratio 3:1 was the best for hypoglycemic effect [37] . At the same time, Radix puerariae and Rhizoma coptidis are main ingredients in the famous prescription, Gegen Qinlian Decoction, for diabetes [25] . So creatively Astragalus membranaceus, Ramulus euonymi, Coptis chinensis and Pueraria lobata were grouped together in a new combination, Qijian Mixture, for T2D. Based on the previous study [38] and recommended clinical dosage, the preliminary proportion of 4 herbs was Astragalus membranaceus (60 g), Ramulus euonymi (20 g), Radix puerariae (15 g), and Rhizoma coptidis (5 g) per day for human beings. Qijian Mixture granula was offered by Beijing Kang Rentang pharmaceutical industry (Beijing, China). The conversion of the raw medicinal materials and the granula was as follows: Astragalus membranaceus (700:100), Winged Euonymus Twig (1667:100), Radix Puerariae (1250:100), and Rhizoma Coptidis (1100:100). According to the equivalent conversion between animal and people by body surface area, normal dosage of 1.795 g/kg is chosen in present study for mice per day.
UPLC chromatogram of qijian mixture
The UPLC-QTOF-MS characteristic chromatogram of Qijian mixture is shown in Fig. 1A . Qijian mixture contains a wide range of compounds, which could be mainly distributed into six classes, including flavones (formononetin; calycosin; berlambine; berberrubine; berberine puerarin; 3 -hydroxy puerarin; 4 -methoxy puerarin; soyasaponin bb;
aglycones (obacunoic acid), fats (linolenic acid) and organic acid (citric acid).
Acute toxicity study
The mice in the Qijian mixture group had less activities, brown, soft and watery faeces on the day of administration, and the defecation function turned normal the next day. All mice in four groups had normal breathing, without abnormal behaviors or automatic behaviors. Corneal, righting and stretch reflex were present, no treas or proptosis. During the 14-day observation, the general condition of mice were good, with normal food-intake, increased weight, smooth and luster hair, and no significant change in urine. No animal deaths occurred throughout the experiment. At the end of experiment, all animals were sacrificed and conducted anatomic observation: there was no obvious pathological changes of heart, liver, spleen, lung, kidney, brain, adrenal gland, thymus, thyroid, trachea, esophagus, stomach, duodenum, colon, bladder, testis, uterus, ovary, and other organs. The weight gain of control group and administrated group was consistent. There was nonsignificant (P > .05) difference of weight gain between the male and female animals (Supplementary Online Fig. 1 and Supplementary Online Table  2 ). The maximum dosage of this experiment was 187.2 g/kg mice weight, which was equivalent to 104 times of the recommended daily dose for human beings.
Biochemistry profiles
The detailed data of eight weeks weight, FBG, OGTT, TC and INS for 6 groups are shown in Supplementary Online Table 2 .
About 8 weeks weight, there was statistically non-significant (P > .05) difference between QJM(L), QJM(H), GGQL, Metformin and Model, revealing the absence of any effect of the initial weight on FBG (Fig. 1B) .
QJM(H), GGQL and Metformin groups exhibited promising hypoglycemic effect after 8 weeks FBG study, compared with Model group, while there was non-significant (P > .05) effect in QJM(L) group. A slight alleviation in glucose level was seen in QJM(H) and GGQL groups. QJM(H) group was lesser effective than metformin hydrochloride; however, both showed similar hypoglycemic trend (Fig. 1C) . In OGTT and TC study, Model group showed significantly (P < .01) higher values of AUC and TC, respectively than that of Control group, while QJM(H), GGQL, and Metformin groups showed lower values than Model group with P < .01, respectively. There was non-significant (P > .05) between QJM(H) and metformin hydrochloride about regarding OGTT or TC (Fig. 1D,E) .
The INS study showed that Model group exhibited higher level of INS than Control group with P < .01, QJM(H) group was higher than Model group with P < .05, while QJM(H) group was higher than Metformin group with P < .01 (Fig. 1F) .
As QJM(L) exhibited non-significant (P > .05) hypoglycemic effect, so we focused on the comparisons during Control, Model, QJM(H) and Metformin groups to reveal the possible mechanism of Qijian Mixture.
Histological examination
According to the images of histological examination of liver, the structure of liver lobule was clear, and the liver cells were radially distributed around the central vein in the Control group (Fig. 2) . The size and shape of liver cells was normal, with a clear nucleus located in the center. No steatosis or necrosis was seen in liver cells (Fig. 2A) . Compared with the Control group, the structure of liver lobule was disappeared, the arrangement of liver cord was disordered, and the hepatic sinusoid were widened. Steatosis and focal necrosis was seen in liver cells, accompanied by inflammatory cell infiltration in Model group (Fig. 2B) . In QJM(H) group, the structure of the hepatocellular cord was clear, the liver sinusoids were normal, and lipid droplets of different sizes in cytoplasm with focal steatosis in hepatocytes were observed (Fig. 2C) . Compared with Model group, Metformin group showed that the hepatocellular cord structure was clear, the liver sinusoids were normal and the cytoplasm of the liver cells had mild steatosis (Fig. 2D) .
As evident from the images of histological examination of kidney, glomeruli, renal tubules and interstitial tissues were normal in Control group under light microscope (Fig. 2E) . Compared with Control group, Model group showed severe proliferation of mesangial cell, vacuoloid changes in tubular epithelial cell, and balloon wall segmental adhesions and expansions (Fig. 2F) . In QJM(H) group, mesangial cells were moderately proliferated, with slight vacuoloid changes of renal tubular epithelial cells and less expansion of the balloon wall (Fig. 2G) . Compared with Model group, the mesangial cells were slightly proliferated and the vacuoloid changes of renal tubular epithelial cells were significantly reduced with rare expansion of the balloon wall in Metformin group (Fig. 2H) .
These findings elaborated that high dose Qijian mixture and Metformin hydrochloride alleviated the damage of the liver and kidney.
Metabolite assignment with 1H NMR spectroscopy
The representative 1 H NMR spectra of liver samples and the assigned metabolites from the Control, Model, QJM(H) and Metformin groups were shown in Supplementary Online Fig. 2A , while Supplementary Online Fig. 2B showed the spectra of kidney samples. NMR spectral data were analyzed and the specific metabolites were assigned for 1 H resonances using the literature data and applying Chenomx NMR Suite 6.0 (Chenomx, Edmonton, Canada), which contained a database of known metabolites with referenced spectral resonant signatures and frequencies. The observed frequencies of the spectra in this study were matched to the known resonant frequencies, and a multivariate analysis of these data was conducted.
Multivariate data analysis and the selection of potential biomarkers
Initially, PCA was conducted to detect liver and kidney patterns. The significant separation among Control, Model, QJM(H) and Metformin groups was observed from the PCA analysis in both liver (Fig. 3A) and kidney samples (Fig. 3E) .
Both QJM(H) and Metformin group patterns were closer to Control group than Model group for liver and kidney samples.
Then 6 OPLS-DA were compared to identify and characterize metabolites.
The significant differences for liver samples were obtained for the following groups: Model vs. Control, cumulative R2Y at 0.931 and Q2 at 0.836 (Fig. 3B) ; QJM(H) vs. Model, R2Y at 0.863 and Q2 at 0.617 (Fig. 3C) ; and Metformin vs. Model, R2Y at 0.813 and Q2 at 0.272 (Fig. 3D) .
The significant differences for kidney samples were obtained for the following groups: Model vs. Control, cumulative R2Y at 0.992 and Q2 at 0.974 (Fig. 3F) ; QJM(H) vs. Model, R2Y at 0.919 and Q2 at 0.593 (Fig. 3G) ; and Metformin vs. Model, R2Y at 0.876 and Q2 at 0.574 (Fig. 3H) .
The pattern results of both QJM(H) vs. Model were better than the Metformin vs. Model.
The metabolites with VIP values >1.0 and adjusted p-values <.05 for liver appear in Table 1 . There were 14 specific metabolic biomarkers for distinguishing Model vs. Control, 17 for QJM(H) vs. Model, and 14 for Metformin vs. Model. The metabolites included isoleucine, valine, lactate, alanine, acetate, homoserine, glutarate, 3-hydroxybutyrate, glutamine, glutathione, choline, glucose, taurine, glycerol, anserine, niacinamide, xanthine, and inosine, and the heat map of above 18 metabolites during the 4 groups (Model, Control, QJM(H) and Metformin) was shown in Fig. 4B .
The metabolites with VIP values >1.0 and adjusted p-values <.05 for kidney appear in Table 2 . There were 12 specific metabolic biomarkers for distinguishing Model vs. Control, 5 for QJM(H) vs. Model, and 7 for Metformin vs. Model. The metabolites included isoleucine, leucine, valine, lactate, citrate, sn-glycero-3-phosphocholine, trimethylamine n-oxide, myo-inositol, glycine, glucose, xanthine, adenine, and niacinamide, and the heat map of above 13 metabolites during the 4 groups (Model, Control, QJM(H) and Metformin) was shown in Fig. 4D. 
Pathway analysis
Based on the identified biomarkers, the main changed metabolic pathways of diabetes in the liver were Valine, leucine and isoleucine biosynthesis; Aminoacyl-tRNA biosynthesis; Alanine, aspartate and glutamate metabolism; and Galactose metabolism (Fig. 4A) . Detailed pathways for Model vs. Control, QJM(H) vs. Model and Metformin vs. Model were shown in the Supplementary Online Table 3 .
On the basis of the identified biomarkers, the key altered metabolic pathways of diabetes in the kidney were Valine, leucine and isoleucine biosynthesis and Aminoacyl-tRNA biosynthesis (Fig. 4C) . Detailed pathways for Model vs. Control, QJM(H) vs. Model and Metformin vs. Model were shown in the Supplementary Online Table 4 .
Correlation network of differential proteins
Apart from above characteristically altered metabolites, we constructed the metabolism-protein networks and identified the related proteins, as narrated in Fig. 5 and Table 3 . The detailed information of metabolites, proteins and pathways are also shown in Supplementary Online Table 5 .
Overall structural modulation of gut microbiota
In total, 1692448 cleaned sequences were obtained from 24 fecal samples with an average length of 254 ± 2 bp, and the number of sequences varied from 18950 to 97839 (median = 73687) (Supplementary Online Table 6 ). A total of 1585 operational taxonomic units (OTUs) were obtained from 24 samples representing 23 bacterial phyla (Supplementary Online Table 6 ). According to rarefaction curves (Supplementary Online Fig. 3) , Chao1, phylogenetic diversity, the observed number of OTUs and Good's coverage estimator (Supplementary Online Table 6 ), 18950 reads per sample could captured most of the abundant microbial OTUs.
There were 312 shared OTUs for 4 groups, and 251, 41, 61, and 274 special OTUs for Control, Model, QJM(H) and Metformin group (Fig. 6A) . Due to weighted UniFrac PCoA analysis, the gut microbiota structure of the QJM(H) and Metformin groups showed same trend and both of them were far from the Model group. It means that the gut microbiota structure of QJM(H) and Metformin group recovered to Control group (Fig. 6B) . The top 10 phyla in 4 groups were shown in Fig. 6(C) . The most phylum were firmicutes, bacteroidetes, actinobacteria and proteobacteria. The heat map of top 35 Genus in 4 groups were shown in Fig. 6(D) . The dominant Genus in Control group were Allobaculum, Prevotella, Kurthia, Streptococcus and Dialister. The dominant Genus in QJM(H) group were Lachnospiraceae NK4A136 group, Ruminococcaceae UCG 014, Lactococcus, Enterorhabdus, Odoribacter, Unidentified Lachnospiraceae, Ruminococcaceae UCG 013, Alistipes, Prevotellaceae UCG 001 and Parabacteroides. The dominant Genus in Model group were Phyllobacterium, Lactobacillus, Lachnoclostridium, Pseudomonas, Corynebacterium 1, Aerococcus, Weissella, Jeotgalicoccus and Staphylococcus. The dominant Genus in Metformin group were Enterococcus, Parasutterella, Rikenellaceae RC9 gut group, Bacteroides, Anaerostipes, Alloprevotella, Escherichia Shigella, Akkermansia, Erysipelatoclostridium, Proteus and Blautia.
Microbial communities comparisons of 4 groups
LEfSe is a software to find signals of the high dimensional beings and uncover the features of genome. Its algorithm emphasizes the statistical significance and biological relevance.
The histogram of distribution of LDA values shows creatures with a bigger set LDA score value (with as default setting), which is the biomarker of the statistical difference between groups. It shows creatures with significant difference of gene abundance in different groups, and the length of histogram indicates the extent of influence (LDA Score) of different creatures (Fig. 7A, C and E) .
In the diagram of evolutionary branch, the circles radiating from inside to outside represent the classification level from phylum to genus. The small circles in each classification represent the sub-category of that level, and the diameter of small circle is proportional to the relative abundance. Coloring principle is as: Creatures without significant difference are colored as yellow, and biomarker are colored according to the groups, the red nodes indicate microbial groups that play an important role in the red group, and green nodes indicate microbial groups that play an important role in the green group. The creatures represented by English letters in the diagram are presented in the legend on the right side (Fig. 7B, D and E) . figure, d means a double peak, dd mean a higher peak & a lower peak, t means a triplet peak, q means a quartet peak, and m means a multiplet peak. * compared with M group, p < .05. ** compared with M group, p < .01. figure, d means a double peak, dd mean a higher peak & a lower peak, t means a triplet peak, q means a quartet peak, and m means a multiplet peak. * compared with M group, p < .05. ** compared with M group, p < .01. Fig. 5 . Metabolism-Protein Networks in Galactose metabolism, Valine, leucine and isoleucine degradation metabolism, Aminoacyl-tRNA biosynthesis metabolism and Alanine, aspartate and glutamate metabolism pathways.
Table 3
The metabolism-protein networks and the related proteins.
No. Networks
Names of the related proteins 1 Galactose metabolism pathway Aldose reductase, lactase-phlorizin hydrolase, ␣-galactosidase A, ␤-galactosidase, aldo-keto reductase family 1 member B10, glucokinase, hexokinase-3, hexokinase-2, hexokinase-1, sucrase-isomaltase intestinal, ␤-1,4-galactosyltransferase 2, ␣-lactalbumin, glucose-6-phosphatase, ␤-1,4-galactosyltransferase 1, phosphoglucomutase-1, lysosomal ␣-glucosidase, maltase-glucoamylase intestinal, glucose-6-phosphatase 3, glucose-6-phosphatase 2, neutral ␣-glucosidase C, and putative hexokinase HKDC1 2
Valine, leucine and isoleucine degradation metabolism pathway Branched-chain-amino-acid aminotransferase (cytosolic), branched-chain-amino-acid aminotransferase (mitochondrial), propionyl-CoA carboxylase ␤-chain (mitochondrial), L-amino-acid oxidase, 4-aminobutyrate aminotransferase (mitochondrial), and short/branched chain specific acyl-CoA dehydrogenase 3
Aminoacyl-tRNA biosynthesis metabolism pathway Probable leucine-tRNA ligase (mitochondrial), leucine-tRNA ligase (cytoplasmic), glutamine-tRNA ligase, glutamyl-tRNA (Gln) amidotransferase subunit A (mitochondrial), glutamyl-tRNA (Gln) amidotransferase subunit C (mitochondrial), valine-tRNA ligase (mitochondrial), valine-tRNA ligase, alanine-tRNA ligase (cytoplasmic), alanine-tRNA ligase (mitochondrial), glycine-tRNA ligase, and isoleucine-tRNA ligase (mitochondrial) 4 Alanine, aspartate and glutamate metabolism pathway Glutamate decarboxylase 2, glutamate decarboxylase 1, glutamine-fructose-6-phosphate aminotransferase 1, asparagine synthetase, glutamine-fructose-6-phosphate aminotransferase, glutaminase kidney isoform, mitochondrial, glutaminase liver isoform, glutamine synthetase, amidophosphoribosyltransferase, CAD protein, L-amino-acid oxidase, ␤-citryl-glutamate synthase B, serine-pyruvate aminotransferase, alanine aminotransferase 2, alanine-glyoxylate aminotransferase 2 (mitochondrial), alanine aminotransferase 1 and The detailed data for kingdom, phylum, class, order, family, genus, and species were shown in Supplementary Online Table 6 .
Systematic investigation of mechanism of antidiabetic effect
The literature search of Qijian mixture revealed a total of 95 chemical constituents and 207 potential protein targets. The retrieved chemical constituents included astraglans, astraisoflavans, Isoastragalosides, astrafalussaponins, agroastragaloside, kaempferol, isorhamnetin, calycosin, quercetin, melampyrin, berberine, coptisine, daidzein, puerarin, genistein, formononetin, glycitein, and kakkalide. Out of these, 133 targets were ascertained to have association with diabetes. While, the normalization through UniProt database mapping (http://www.uniprot.org/) revealed that Homo sapiens contained 111 targets. The protein targets retrieved at medium probabilistic confidence score = 0.400 along with 11 predicted functional partners (All are having confidence score = 0.999) are presented as nodes in interaction network in Fig. 8(A) . Network nodes indicate protein targets or the relevant genes. According to network statistics, the average node degree was 12.2, revealing that there are 35 hubs (Supplementary Online  Table 7 ). TP53 hub showed the highest degree, i.e. 53, followed by AKT1 and PPARA hubs with 46 and 45 • , respectively. These hubs, particularly TP53, AKT1, PPARA, MTOR, NOS3, CCND1, MAPK1 and MAPK3, have been already described to be involved in type 2 diabetes [39] [40] [41] [42] . In addition, the action view of interaction network shows that Qijian mixture can activate all its functional partners, but bind with and inhibit CCND3, NFKB1A, AXIN1 and TCF7L2. Qijian mixture is also found to be involved in the catalysis, post-translational modifications, reactions and expression. Moreover, ClueGO-mediated enrichment analysis evolved to significant enrichment of GO terms, which were grouped into 9 classes. These sub-groups were mainly involved in galactose metabolic processes, hexose transmembrane transport, negative regulation of lipid transport, secondary metabolic pathways, ammonium ion metabolic process, flavone metabolic process, and protein ADP-ribosylation (Supplementary Online Table 8 , Fig. 8B ). These observations are useful in better understanding of the mechanisms of Qijian mixture.
Discussion
The distressing complications of diabetes and the inability of current remedies to treat all aspects of diabetes and its complications describe a vital need to search effective therapeutic moieties. The efficacy of TCM treating T2D has been confirmed through several hundred years' practice [38] . The results of current study, for the first time, revealed that Qijian mixture, similar to other natural compounds including cinnamaldehyde [43] , natural stilbenoids [44] , and Antirhea borbonica extracts [45] , exerted a promising glycemic control in blood.
The literature does not report any study on the efficacy and safety of Qijian mixture. The current study proposed that Qijian mixture treatment exerted significant inhibitory effect on FBG compared with untreated group. Insulin level, oral glucose tolerance and TC level was profoundly alleviated by high dose of Qijian mixture; these findings were in accordance with previously reported findings on another TCM, Gegen Qinlian Decoction [38] . Metformin showed the best hypoglycemic effect in this research, and QJM(H) group showed the similar hypoglycemic trend. QJM(H) group was almost equal to the Metformin group in OGTT and TC level, and, at the same time, QJM(H) group showed significant increase in INS than Metformin. Moreover, histological examinations revealed a slight reduction in inflammation in QJM(H) group. This observation was in accordance with a reported NMR-based study in Gegen Qinlian Decoction-treated diabetic mice [46] . It is evident from these data that glycemic level can effectively be controlled using the Chinese herbal formula.
After testing antidiabetic potential, the mechanism of Qijian mixture was assessed by metabolomics test. For this analysis, the liver and the kidney samples were collected and identified the profoundly altered metabolites in the treated groups. According to the results, major metabolites after Qijian mixture treatment were isoleucine, leucine, valine, citrate, lactate, alanine, acetate, homoserine, glutarate, 3-hydroxybutyrate, glutamine, glutathione, choline, sn-glycero-3-phosphocholine, glucose, taurine, glycerol, anserine, niacinamide, xanthine, inosine, trimethylamine n-oxide, myo-inositol, glycine and adenine. Leucine, Isoleucine and Valine are essential amino acids having branched chains. These amino acids mainly responded to the suppressive insulin action on amino acid removal from skeletal muscles. The metabolism of these amino acids is considerably changed in diabetic conditions [47] . In particular, leucine-mediated stimulation of insulin release promotes protein synthesis and suppresses protein degradation [48] . Moreover, Alanine regulates glucose metabolism, thus the level of Alanine is always in proportion with the level of blood sugar [49] . Since Qijian mixture-treated group had higher levels of leucine, isoleucine, valine and alanine compared with Control group, the current study showed that the Qijian mixture could profoundly modulate the regulation of amino acid metabolism by decreasing the level of Leucine, Isoleucine, Valine and Alanine. The mechanism of Qijian mixture was further explored by constructing the metabolite-associated network, and retrieving Qijian mixture-related 55 proteins as well as Qijian mixture-related 4 signaling pathways, i.e. galactose metabolism, valine, leucine and isoleucine degradation metabolism, Aminoacyl-tRNA biosynthesis metabolism and alanine, aspartate and glutamate metabolism pathways. It is obvious that these identified pathways were in consistence with the metabolite profiles of the test groups.
Moreover, galactose metabolism is not only important for the generation of energy in cell, but also contribute to modification in glycolipids and glycoproteins [50] . Valine, Leucine and Isoleucine degradation metabolism is linked with insulin sensitivity: The increase in the level of Valine, Leucine and Isoleucine in serum promotes the impairment in insulin sensitivity [51] . Aminoacyl-tRNA was found to be involved in neurodegenerative diseases [52] . Alanine, aspartate and glutamate metabolism pathways contribute to the pathogenesis of metabolic syndromes such as T2D [53] . Thus, the 4 pathways have close association with T2D, which confirm the therapeutic potential of Qijian mixture in T2D.
In addition to the ameliorated glycemic control, Qijian mixture treatment altered the microbial composition also. Various studies have described the use of probiotics [12] , drugs [17] and food [54] for gut microbiota modulation in metabolic diseases. For instance, metformin-treated HFD-induced obese mice showed an increase in Akkermansia spp. in the process of glycemic alleviation [55] . The major component of Qijian mixture is berberine, which is involved in enrichment of short-chain fatty acid processes, associated with the prevention of insulin resistance and weight gain in rats [17] . Radix puerariae is the main component of Qijian mixture. However, the literature survey reveals no study on the modulation of gut microbiota by berberine or Radix puerariae. Thus, the current study is first of its kind on the gut microbiota modulation by Qijian mixture or its components.
Different doses of Qijian mixture alleviate T2D to different extents. Similarly, the degree of gut microbiota modulation also depends on the dose of Qijian mixture. It suggests that T2D amelioration is strongly linked with the gut microbiota modulation. The prebiotic studies have also reported the modulation of gut microbiota in a dose-dependent manner. For instance, the stepwise increase in dose of galactooligosaccharides resulted in the sequential increase in bifidobacteria [56] . The current study describes that both the gut microbiota modulation and T2D amelioration depend on the administered dose in rats. In addition, the modification of gut microbiota leads to T2D amelioration, arguing that Qijian mixturemediated alteration in the gut microbiota might be responsible for the alleviated diabetic condition.
The redundancy analysis showed that several putative beneficial bacteria including firmicutes and bacteroidetes were affected by Qijian mixture treatment, which enriched bacteroidetes. These bacteria exert anti-inflammatory effects partly via decreasing the production of cytokines in gut and enhancing the secretion of anti-inflammatory cytokines [57] . Compared with non-diabetic obese individuals, diabetic obese individuals have higher contents of firmicutes, while lower contents of bacteroidetes. This gut microbiota shift not only induces inflammation due to increased level of plasma lipopolysaccharides (LPS), but also diminishes glucagonlike peptide 2 (GLP-2) synthesis. GLP-2 promotes cellular tight junctions and reduces LPS entry into plasma. Thus, the altered gut microbiota-induced diminished levels of GLP-2 results in enhanced gut permeability and plasma LPS concentration [58] . The elevated level of LPS contribute to TLR4 activation as well as upregulation of pro-inflammatory cytokines, triggering inflammatory response that eventually leads to obesity and T2D [58] . The gut microbiota shift has negative association with inflammatory cytokines [57] . In present study, negative correlation between bacteroidetes and FBG was observed, showing the likely potential association between and bacteroidetes and T2D alleviation.
The system pharmacology provides easy paradigms in TCM research to assess the multi-target influences of drug action and theoretical perception of biological network functioning [20] . To better understand the molecular mode of the therapeutic effect of Qijian mixture on T2D, protein interaction network was established on the basis of the network pharmacology. It consisted of 95 chemical ingredients, 207 molecular targets and their nine relevant functional annotations. The analysis revealed that multiple targets hit by the same chemical or different chemicals acting on the same targets produce more probabilities to affecting the entire balance of networks, which make Qijian mixture treatment more efficacious.
Chinese healthcare system has a long history of TCMs, which are the mixtures of several active chemicals. Owing to their complex chemical composition, the mechanisms of action of TCMs are still vague. The current study describes the efficacy and safety of a new TCM, Qijian mixture that exhibits its ameliorative effect in T2D, likely through the gut microbiota modulation. Qijian mixture contains several active compounds including formononetin, calycosin, and puerarin. Formononetin is an isoflavonone that exerts anti-hyperglycemic effect via stimulation of insulin release [59] . Calycosin improves diabetes and its associated complications such as impaired cognition [60] . Puerarin is a dietary flavone that normalizes glycemic level and ameliorates glucose tolerance through its action on ␤-cell survival and GLP-1R pathway [61] . These compounds could have an impact on gut microbiota, but the literature survey does not show any study of this kind. Qijian mixture contained carbohydrates also, which probably affected gut microbiota, as evident the from detection of minor quantities of dietary fibers. Moreover, the quantities of these carbohydrates were similar across different strengths of Qijian mixture. Other carbohydrate components, for instance starch, were digested and absorbed prior to their access to colon. These findings determine that gut microbiota modulation by Qijian mixture components might be involved in ameliorating glycemic control. Thus, due to its potential to target gut microbiota, Qijian mixture could be used as a new medication for managing diabetes.
Conclusion
The above given results describe the therapeutic potential of Qijian mixture in T2D. The mechanism of Qijian mixture was studied by using 1 H NMR-based metabonomics approach in combination with multivariate data analysis. Qijian mixture was found to play role in adjusting the concentrations of different metabolites in the amino acid and carbohydrate metabolism, normalizing the metabolic phenotype, and regulating metabolic disorders. The metabolite biomarkers were used for the identification of Qijian mixture-related proteins and the associated pathways. The retrieved pathways revealed a close association of Qijian mixture with T2D. The above results also lead to a conclusion that Chinese herbal combination, Qijian mixture, induces the structural changes in gut microbiota. These changes are related to the antidiabetic effects of Qijian mixture. Especially, this phytotreatment resulted in the enrichment of useful bacteria, including bacteroidetes in the gut. Based on current positive hypoglycemic effect, about the perspective of deeper studies, we hope to assess the following items: 1) based on the Probability Ensemble Approach [62] , effects of possible different monomers combinations from Qijian Mixture on T2D, to refine the mixture and enhance the effectiveness; 2) regulatory mechanism of the best monomers combination for predicted proteins from system pharmacology on both cell and mice levels; 3) suitable method to detect the systematic relationship on pro-teins, regulatory pathways and microbiota not just in vitro, but also directly in vivo.
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